vs
STANDARD BIOTOOLS INC.（LAB）与Meridian Corp（MRBK）财务数据对比。点击上方公司名可切换其他公司
Meridian Corp的季度营收约是STANDARD BIOTOOLS INC.的1.8倍（$34.2M vs $19.6M），Meridian Corp净利率更高（428.0% vs -177.4%，领先605.4%），Meridian Corp同比增速更快（5.1% vs -11.5%），Meridian Corp自由现金流更多（$22.6M vs $-23.1M），过去两年Meridian Corp的营收复合增速更高（18.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
英国子午线音响是一家消费音响与家庭影院设备制造商，由鲍勃·斯图尔特与艾伦·布思罗伊德于1977年创立，最初名为Boothroyd-Stuart。1985年该公司推出了首款以Meridian为品牌的CD播放器，1998年研发了无损压缩格式Meridian Lossless Packing，2014年推出了Master Quality Authenticated认证有损音频格式MQA。
LAB vs MRBK — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $34.2M |
| 净利润 | $-34.7M | $7.2M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 27.2% |
| 净利率 | -177.4% | 428.0% |
| 营收同比 | -11.5% | 5.1% |
| 净利润同比 | -28.8% | 28.3% |
| 每股收益（稀释后） | $-0.09 | $0.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $34.2M | ||
| Q3 25 | $19.6M | $33.1M | ||
| Q2 25 | $21.8M | $32.4M | ||
| Q1 25 | $40.8M | $27.1M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | $22.1M | $29.1M | ||
| Q2 24 | $22.5M | $26.1M | ||
| Q1 24 | $45.5M | $24.6M |
| Q4 25 | — | $7.2M | ||
| Q3 25 | $-34.7M | $6.7M | ||
| Q2 25 | $-33.5M | $5.6M | ||
| Q1 25 | $-26.0M | $2.4M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | $-26.9M | $4.7M | ||
| Q2 24 | $-45.7M | $3.3M | ||
| Q1 24 | $-32.2M | $2.7M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 27.2% | ||
| Q3 25 | -168.5% | 26.2% | ||
| Q2 25 | -118.1% | 22.5% | ||
| Q1 25 | -80.8% | 11.6% | ||
| Q4 24 | — | 23.3% | ||
| Q3 24 | -120.9% | 21.5% | ||
| Q2 24 | -134.5% | 16.8% | ||
| Q1 24 | -132.2% | 14.4% |
| Q4 25 | — | 428.0% | ||
| Q3 25 | -177.4% | 20.1% | ||
| Q2 25 | -153.7% | 17.2% | ||
| Q1 25 | -63.8% | 8.9% | ||
| Q4 24 | — | 366.8% | ||
| Q3 24 | -122.0% | 16.3% | ||
| Q2 24 | -203.3% | 12.7% | ||
| Q1 24 | -70.6% | 10.9% |
| Q4 25 | — | $0.61 | ||
| Q3 25 | $-0.09 | $0.58 | ||
| Q2 25 | $-0.09 | $0.49 | ||
| Q1 25 | $-0.07 | $0.21 | ||
| Q4 24 | — | $0.49 | ||
| Q3 24 | $-0.07 | $0.42 | ||
| Q2 24 | $-0.12 | $0.30 | ||
| Q1 24 | $-0.27 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $199.7M |
| 总资产 | $539.6M | $2.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $199.7M | ||
| Q3 25 | $399.7M | $188.0M | ||
| Q2 25 | $424.5M | $178.0M | ||
| Q1 25 | $454.6M | $173.6M | ||
| Q4 24 | — | $171.5M | ||
| Q3 24 | $489.3M | $167.4M | ||
| Q2 24 | $510.3M | $162.4M | ||
| Q1 24 | $577.3M | $159.9M |
| Q4 25 | — | $2.6B | ||
| Q3 25 | $539.6M | $2.5B | ||
| Q2 25 | $557.0M | $2.5B | ||
| Q1 25 | $579.6M | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $681.5M | $2.4B | ||
| Q2 24 | $708.7M | $2.4B | ||
| Q1 24 | $777.7M | $2.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $24.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $22.6M |
| 自由现金流率自由现金流/营收 | -118.1% | 65.9% |
| 资本支出强度资本支出/营收 | 4.5% | 5.1% |
| 现金转化率经营现金流/净利润 | — | 3.38× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $51.7M |
8季度趋势，按日历期对齐
| Q4 25 | — | $24.3M | ||
| Q3 25 | $-22.2M | $24.4M | ||
| Q2 25 | $-20.7M | $-12.0M | ||
| Q1 25 | $-30.3M | $18.1M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $-27.9M | $31.2M | ||
| Q2 24 | $-39.0M | $-19.2M | ||
| Q1 24 | $-62.5M | $-1.7M |
| Q4 25 | — | $22.6M | ||
| Q3 25 | $-23.1M | $24.0M | ||
| Q2 25 | $-22.6M | $-12.7M | ||
| Q1 25 | $-35.3M | $17.9M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | $-30.1M | $29.5M | ||
| Q2 24 | $-41.0M | $-19.3M | ||
| Q1 24 | $-63.3M | $-3.6M |
| Q4 25 | — | 65.9% | ||
| Q3 25 | -118.1% | 72.4% | ||
| Q2 25 | -103.6% | -39.1% | ||
| Q1 25 | -86.6% | 65.9% | ||
| Q4 24 | — | 27.7% | ||
| Q3 24 | -136.4% | 101.4% | ||
| Q2 24 | -182.2% | -73.8% | ||
| Q1 24 | -138.9% | -14.7% |
| Q4 25 | — | 5.1% | ||
| Q3 25 | 4.5% | 1.4% | ||
| Q2 25 | 8.7% | 1.9% | ||
| Q1 25 | 12.4% | 1.0% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | 10.2% | 6.0% | ||
| Q2 24 | 8.6% | 0.2% | ||
| Q1 24 | 1.7% | 7.8% |
| Q4 25 | — | 3.38× | ||
| Q3 25 | — | 3.66× | ||
| Q2 25 | — | -2.15× | ||
| Q1 25 | — | 7.55× | ||
| Q4 24 | — | 1.71× | ||
| Q3 24 | — | 6.58× | ||
| Q2 24 | — | -5.78× | ||
| Q1 24 | — | -0.64× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
MRBK
暂无分部数据
